Obshchestvo S Ogranichennoy Otvetstvennostyou "Fusion Pharma"; territory of the Skolkovo innovation center
发明人:
Chilov, Germes Grigorievich,Titov, Ilya Yurievich
申请号：
HRP20161478
公开号：
HRP20161478T1
申请日:
2016.11.08
申请国别(地区):
HR
年份:
2016
代理人:
摘要：
The present invention relates to the treatment of oncological, chronic inflammatory and similar diseases with the aid of new families of chemical compounds having improved efficiency with regard to the inhibition of Abl kinase and mutant forms thereof, as well as other therapeutically significant kinases. It describes protein kinase inhibitors in the form of compounds of general formula (I) and compounds of general formula (II), or a tautomer, an individual isomer, a mixture of isomers, a pharmaceutically acceptable salt, a solvate or a hydrate thereof.
